Back to TRDA
BARCLAYS PLC TRDA Position History
Entrada Therapeutics, Inc. • Healthcare
Quarters held
27
Latest value
$448K
Q3 2026
Peak value
$888K
First seen
Q4 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2022 | $146K |
| Q1 2023 | $66K |
| Q1 2023 | $83K |
| Q2 2023 | $96K |
| Q2 2023 | $1K |
| Q3 2023 | $94K |
| Q4 2023 | $479K |
| Q1 2024 | $319K |
| Q2 2024 | $207K |
| Q3 2024 | $721K |
| Q4 2024 | $888K |
| Q1 2025 | $358K |
| Q2 2025 | $390K |
| Q2 2025 | $74 |
| Q3 2025 | $352K |
| Q3 2025 | $64 |
| Q3 2025 | $721K |
| Q3 2025 | $352K |
| Q3 2025 | $64 |
| Q4 2025 | $690K |
| Q4 2025 | $113 |
| Q1 2026 | $357K |
| Q1 2026 | $5K |
| Q1 2026 | $139 |
| Q2 2026 | $204K |
| Q2 2026 | $6K |
| Q3 2026 | $448K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $448K | 70.6K | — | — |
| Q2 2026 | $6K | 842 | — | — |
| Q2 2026 | $204K | 27.8K | — | — |
| Q1 2026 | $139 | 11 | — | — |
| Q1 2026 | $5K | 374 | — | — |
| Q1 2026 | $357K | 28.3K | — | — |
| Q4 2025 | $113 | 11 | — | — |
| Q4 2025 | $690K | 67.1K | — | — |
| Q3 2025 | $64 | 11 | — | — |
| Q3 2025 | $352K | 60.6K | — | — |
| Q3 2025 | $721K | 45.1K | — | — |
| Q3 2025 | $64 | 11 | — | — |
| Q3 2025 | $352K | 60.6K | — | — |
| Q2 2025 | $74 | 11 | — | — |
| Q2 2025 | $390K | 58.1K | — | — |
| Q1 2025 | $358K | 39.7K | — | — |
| Q4 2024 | $888K | 51.4K | — | — |
| Q3 2024 | $721K | 45.1K | — | — |
| Q2 2024 | $207K | 14.5K | — | — |
| Q1 2024 | $319K | 22.5K | — | — |
| Q4 2023 | $479K | 31.7K | — | — |
| Q3 2023 | $94K | 5.9K | — | — |
| Q2 2023 | $1K | 82 | — | — |
| Q2 2023 | $96K | 6.4K | — | — |
| Q1 2023 | $83K | 5.7K | — | — |
| Q1 2023 | $66K | 4.5K | — | — |
| Q4 2022 | $146K | 10.8K | — | — |
Other funds holding TRDA
$18.8M
$18.1M
$15.1M
$14.3M
$12.8M